Gene Editing With CRISPR-Cas9: The Next Step In Human Evolution Will Be Worth $25 Billion By 2030

CRISPR-Cas9 tools have recently created a buzz in the global healthcare industry, with the development of numerous applications-focused solutions—and intensifying patenting disputes. The invention of CRISPR-Cas9 gene editing tools is one of the greatest scientific revolutions of this generation. Despite major controversies around patenting rights and ethical challenges, CRISPR-Cas9 tools have gained popularity with the scientific community and life science companies, primarily due to their ability to accurately cut the DNA sequence. CRISPR-Cas9 has entered commercial application in less than five years from its introduction—far earlier than expected by average technology life cycle theory.